Elysian, the first AI-native third-party administrator (TPA) built for commercial claims, today announced its selection to Lloyd's Lab Cohort 16, the accelerator program at the heart of the world's ...

Hundreds of thousands of people in northern Thailand have become collateral damage from the civil war in neighbouring Myanmar, turning to drugs as supply through the area rockets on the ...

New research has revealed that as the conflict between the US/Israel and Iran continues, scammers are taking advantage of ...

These new models are specially trained to recognize when an LLM is potentially going off the rails. If they don’t like how an interaction is going, they have the power to stop it. Of course, every ...

A student currently enrolled in Somerset Community College Medical Laboratory Technician Program, Emily Cole, has been named recipient of the SCC Health Sciences Division’s Student of the Month award ...

AI startup was blacklisted after refusing to allow its technology to be used for autonomous weapons or domestic surveillance ...

JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web ...

Planet Labs PBC engages in the design, construction, and launch constellations of satellites with the intent of providing high cadence geospatial data delivered to customers through an online platform ...

大英博物馆通过公众募捐筹集了上百万英镑以支付购买这件珠宝。大英博物馆馆长尼古拉斯·库里南表示，公众的响应显示出人们对英国历史的高度珍视。 The pendant will join the museum's collection later this year and is expected to tour the UK.

Your weekly cybersecurity roundup covering the latest threats, exploits, vulnerabilities, and security news you need to know.

CPD accredited public sector news, comment & analysis for Civil Servants responsible for building, shaping and delivering transformational public services. The UK's No1 Public Sector Magazine.

Xenon Pharmaceuticals Inc. XENE-Q generated positive results from a critical late-stage human trial for its epilepsy ...